Real-world data in the United Kingdom: opportunities and challenges

被引:27
|
作者
McDonald, Laura [1 ]
Lambrelli, Dimitra [1 ]
Wasiak, Radek [1 ]
Ramagopalan, Sreeram V. [1 ]
机构
[1] Evidera, Metro Bldg,6th Floor,1 Butterwick, London W6 8DL, England
来源
BMC MEDICINE | 2016年 / 14卷
关键词
Real-world evidence; Care.data; United Kingdom; MEDICAL-RESEARCH; OPT-OUT; REGISTRY; CONSENT; TRIAL;
D O I
10.1186/s12916-016-0647-x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Real-world data is that collected outside the constraints of controlled clinical trials and is increasingly informing decision-making in healthcare. The landscape of real-world data in the United Kingdom is set to evolve over the coming months as the government plans to build on databases currently in place by collecting patient data from all family practices and linking this information with hospital records. This initiative, called care. data, has the potential to be an invaluable resource. However, the programme has been criticized on grounds of data privacy, which has led to an extended delay in its implementation and the expectation that a large number of people will opt out. Opt-outs may introduce substantial biases to the dataset, and understanding how to account for these presents a significant challenge for researchers. For the scope and quality of real-world evidence in the United Kingdom to be realised, and for this information to be used effectively, it is essential to address this challenge.
引用
收藏
页数:3
相关论文
共 50 条
  • [21] Challenges and Opportunities in Interdisciplinary Research and Real-World Data for Treatment Sequences in Health Technology Assessments
    Jen-Yu Amy Chang
    James B. Chilcott
    Nicholas R. Latimer
    PharmacoEconomics, 2024, 42 : 487 - 506
  • [22] Challenges and Opportunities in Interdisciplinary Research and Real-World Data for Treatment Sequences in Health Technology Assessments
    Chang, Jen-Yu Amy
    Chilcott, James B.
    Latimer, Nicholas R.
    PHARMACOECONOMICS, 2024, 42 (05) : 487 - 506
  • [23] REAL-WORLD HEPATITIS C TREATMENT STRATEGIES IN THE UNITED KINGDOM AND DENMARK
    Jalbert, J.
    Lee, Y.
    Thiam, A.
    Bakshi, S.
    Weis, N.
    Hallager, S.
    McLauchlan, J.
    Irving, W.
    Amzal, B.
    VALUE IN HEALTH, 2016, 19 (03) : A221 - A222
  • [24] Current Status, Challenges, and Future Perspectives of Real-World Data and Real-World Evidence in Japan
    Katsutoshi Hiramatsu
    Annabel Barrett
    Yasuhiko Miyata
    Drugs - Real World Outcomes, 2021, 8 : 459 - 480
  • [25] Current Status, Challenges, and Future Perspectives of Real-World Data and Real-World Evidence in Japan
    Hiramatsu, Katsutoshi
    Barrett, Annabel
    Miyata, Yasuhiko
    DRUGS-REAL WORLD OUTCOMES, 2021, 8 (04) : 459 - 480
  • [26] Real-world Data of Antibiotic Prescriptions for Sore Throat in the United Kingdom (UK) Primary Care Practice
    Coutinho, G.
    Duerden, M.
    Hallett, T.
    Pich, O.
    Olaniyan, R.
    Shepard, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [27] Prevalence and Mortality of Individuals With X-Linked Hypophosphatemia: A United Kingdom Real-World Data Analysis
    Hawley, Samuel
    Shaw, Nick J.
    Delmestri, Antonella
    Prieto-Alhambra, Daniel
    Cooper, Cyrus
    Pinedo-Villanueva, Rafael
    Javaid, M. Kassim
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2020, 105 (03): : E871 - E878
  • [28] Real-World Battles with Real-World Data
    Brown, Jeffrey
    Bate, Andrew
    Platt, Robert
    Raebel, Marsha
    Sauer, Brian
    Trifiro, Gianluca
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 254 - 255
  • [29] Known challenges and new possibilities of real-world data
    Schneider, Katharina
    Hess, Steffen
    Weber, Stefanie
    BUNDESGESUNDHEITSBLATT-GESUNDHEITSFORSCHUNG-GESUNDHEITSSCHUTZ, 2024, 67 (02) : 129 - 130
  • [30] Opportunities and challenges in partitioning the graph measure space of real-world networks
    Jozsa, Mate
    Lazar, Alpar S.
    Lazar, Zsolt, I
    JOURNAL OF COMPLEX NETWORKS, 2021, 9 (02)